RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept
  • Home
  • Impact
  • Publications
  • 4ß-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4ß-methyl-5-(3-hydroxyphenyl)morphan pure antagonist

4ß-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4ß-methyl-5-(3-hydroxyphenyl)morphan pure antagonist

Carroll, F., Gichinga, M., Williams, J., Vardy, E., Roth, B., Mascarella, S., Thomas, J., & Navarro, H. (2013). 4ß-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4ß-methyl-5-(3-hydroxyphenyl)morphan pure antagonist. Journal of Medicinal Chemistry, 56(21), 8826 - 8833.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Presidential youth fitness program implementation
Article

Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphoma
Article

The role of noncommunicable diseases in the pursuit of global health security
Article

The impact of the risk functional form assumptions on maximum acceptable risk measures